Drug Shortage Report for SANDOZ ALENDRONATE/CHOLECALCIFEROL
Report ID | 103988 |
Drug Identification Number | 02429160 |
Brand name | SANDOZ ALENDRONATE/CHOLECALCIFEROL |
Common or Proper name | ALENDRON/CHOL |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ALENDRONIC ACID VITAMIN D3 |
Strength(s) | 70MG 5600UNIT |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 4 |
ATC code | M05BB |
ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2020-01-06 |
Estimated end date | 2020-01-24 |
Actual end date | 2020-01-31 |
Shortage status | Resolved |
Updated date | 2020-02-11 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2020-02-11 | French | Compare |
v3 | 2020-02-11 | English | Compare |
v2 | 2020-01-22 | French | Compare |
v1 | 2020-01-22 | English | Compare |
Showing 1 to 4 of 4